- Home
- NEO
NEO
NeoGenomics Inc.
as 03-25-2025 3:32pm EST
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | FORT MYERS |
| Market Cap: | 1.2B | IPO Year: | 1999 |
| Target Price: | $19.78 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.98 - $19.11 | Next Earning Date: | 04-29-2025 |
| Revenue: | $660,566,000 | Revenue Growth: | 11.65% |
| Revenue Growth (this year): | 12.89% | Revenue Growth (next year): | 11.36% |
Latest NeoGenomics Inc. News
NEO Breaking Stock News: Dive into NEO Ticker-Specific Updates for Smart Investing
StockStory
5 days ago
3 Reasons to Sell NEO and 1 Stock to Buy Instead
MT Newswires
8 days ago
NeoGenomics Names Warren Stone President, COO
Business Wire
8 days ago
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
StockStory
12 days ago
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
StockStory
14 days ago
3 Small-Cap Stocks in Hot Water
MT Newswires
16 days ago
NeoGenomics Acquires Pathline
Business Wire
16 days ago
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
Argus Research
22 days ago
NEO: Lowering target price to $10.00
Compare NEO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NEO NeoGenomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.